12:00 AM
 | 
Jun 03, 2013
 |  BC Week In Review  |  Company News  |  Other News

Campus Biotech S.A., Merck KGaA, Ecole Polytechnique Federale de Lausanne (EPFL), University of Geneva (UNIGE) other, pharmaceuticals news

Campus Biotech said the sale of the former headquarters of Merck's Merck Serono S.A. biotech division in Geneva to the consortium behind the Campus Biotech initiative has been finalized. Hansjorg Wyss, the founder of Synthes Inc., which Johnson & Johnson (NYSE:JNJ, New Brunswick, N.J.) acquired last year, and Ernesto Bertarelli, the former CEO of Serono S.A, created Campus Biotech to make the offer and to head the site conversion of the...

Read the full 365 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >